Reassessing site engagement activities

Wednesday, February 1, 2017

Drug development sponsors and CROs increasingly recognize the importance of investigative sites having a stronger, more respected voice in the clinical research community and have begun adopting initiatives designed to incorporate site viewpoints into improving clinical development processes.

[Read More]

Advisory boards amplify patients’ voices

Tuesday, September 15, 2015

A strong and growing desire to solicit feedback directly from patients, ex­perienced participants and their sup­port network is prompting many sponsors and CROs to assess, plan and implement patient advisory panels.

[Read More]